Timing
Purchase and sale flow
PurchasesSales
Stock, pipeline and biotech catalyst intelligence
Reported ownership activity
Activity signal
Reported sales exceed purchases by $1.4MOption exercises, awards, and grants are separated from open-market direction.Timing
Composition
Concentration
Company profile
Avrobio Inc. is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
| Insider trading | Relationship | Date | Transaction | Cost | Shares | Value | Shares total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Terrance Mcguire | Former Director | Aug 21 '26 | Proposed Sale | $37.61 | 10,200 | $383,671 | — | Aug 21 05:58 PM |
| Mcnamara Peter | Chief Scientific Officer | Aug 12 '26 | Option Exercise | $14.71 | 43 | $633 | 55,328 | Aug 14 07:25 PM |
| Mcnamara Peter | Chief Scientific Officer | Aug 12 '26 | Sale | $35.00 | 43 | $1,505 | 55,285 | Aug 14 07:25 PM |
Transactions may include sales, purchases, grants, and option exercises. Directional charts count only purchases and sales; follow the Form 4 link to verify the original SEC filing.